Centre for Human Drug Research | Leiden, Netherlands

Research site

(Unclaimed)

Location

Zernikedreef 8, Leiden, Zuid-Holland, Netherlands

Site insights

Top conditions

Top treatments

ACT-541468

DNL151

IW-6463

Clindamycin

DNL343

Erythromycin

POLB 001

Pregabalin

JNJ-42847922

Lu AG06474

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 67 total trials

A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

2-DG-02 is a randomized, placebo-controlled, double-blind Phase 2 study to investigate the efficacy and safety of 2-Deoxy-D-Glucose as a pre-exposure...

Enrolling

Acute Nasopharyngitis

Other: Placebo

Drug: 2-Deoxy-D-glucose

A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec

In this study, researchers will learn about a study drug called BIIB115 in healthy male volunteers and in participants with spinal muscular atrophy (...

Enrolling

Muscular Atrophy, Spinal

Healthy Volunteer

Drug: BIIB115-Matching Placebo

Drug: BIIB115

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

The combined bacteriostatic and immunomodulatory effects of erythromycin and clindamycin will be explored. Treatment effects will be extensively char...

Enrolling

Acne Vulgaris

Drug: 70% topical ethanol solution

Drug: Clindamycin 1% topical lotion formulation

MAD Study of NX210c (CHDR2235)

This study will investigate the safety and tolerability of multiple intravenous infusions of NX210c with two ascending doses as well as NX210c pharma...

Enrolling

Healthy Elderly

Drug: Placebo

Drug: NX210c

Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Explora...

Enrolling

Muscular Dystrophy, Landouzy Dejerine

Fascioscapulohumeral Muscular Dystrophy

Drug: AOC 1020

Drug: Placebo

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria (CALM-CIndU)

This phase 1b trial will evaluate the effects of EP262 in subjects with Chronic Inducible Urticaria (CIndU), including symptomatic dermographism and...

Active, not recruiting

Chronic Inducible Urticaria

Drug: Oral EP262

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria (CALM-CSU)

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urtica...

Enrolling

Chronic Spontaneous Urticaria

Drug: Placebo

Drug: Oral EP262

Single and Repeat Doses of DMT in Healthy Subjects

This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjec...

Active, not recruiting

Stroke

Drug: Placebo

Drug: N,N-Dimethyltryptamine